Aurobindo Pharma Ltd — Cefixime Exporter Profile
Indian Pharmaceutical Exporter · #3 for Cefixime · $8.0M export value · DGFT Verified
Aurobindo Pharma Ltd is the #3 Indian exporter of Cefixime with $8.0M in export value and 192 verified shipments. Aurobindo Pharma Ltd holds a 4.6% market share in Cefixime exports across 6 countries.
Aurobindo Pharma Ltd — Cefixime Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Cefixime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $4.1M | 122 | 56.7% |
| CANADA | $1.6M | 35 | 21.5% |
| MALTA | $861.4K | 91 | 11.9% |
| UNITED STATES | $500.0K | 10 | 6.9% |
| BULGARIA | $131.9K | 8 | 1.8% |
| ITALY | $85.4K | 2 | 1.2% |
Aurobindo Pharma Ltd exports Cefixime to 6 countries. The largest destination is FRANCE accounting for 56.7% of Aurobindo Pharma Ltd's Cefixime shipments, followed by CANADA (21.5%) and MALTA (11.9%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefixime from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYLAN IRELAND LIMITED, | FRANCE | $1.7M | 54 |
| MYLAN IRELAND LIMITED | FRANCE | $875.2K | 19 |
| AURO PHARMA INC, | CANADA | $771.2K | 17 |
| AURO PHARMA INC | CANADA | $696.4K | 15 |
| ARROW GENERIQUES, | FRANCE | $508.1K | 17 |
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $371.1K | 34 |
| ARROW GENERIQUES | FRANCE | $281.8K | 8 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $250.0K | 5 |
| APL SWIFT SERVICES (MALTA) LIMITED, | MALTA | $165.7K | 12 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $141.6K | 9 |
Aurobindo Pharma Ltd supplies Cefixime to 33 buyers globally. The largest buyer is MYLAN IRELAND LIMITED, (FRANCE), followed by MYLAN IRELAND LIMITED (FRANCE) and AURO PHARMA INC, (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefixime Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $61.9M worth of Cefixime through 8,398 shipments from 668 suppliers to 131 countries, serving 1,805 buyers globally. Aurobindo Pharma Ltd contributes $8.0M to this total, accounting for 4.6% of India's Cefixime exports. Aurobindo Pharma Ltd ships Cefixime to 6 countries through 33 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Cefixime Exports?
Aurobindo Pharma Ltd's average Cefixime shipment value is $41.6K per consignment, based on 192 shipments totaling $8.0M. The largest destination is FRANCE (56.7% of Aurobindo Pharma Ltd's Cefixime exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Cefixime Exporters?
Aurobindo Pharma Ltd ranks #3 among 668 Indian Cefixime exporters with a 4.6% market share. The top 3 exporters are MICRO LABS LIMITED ($19.1M), AUROBINDO PHARMA LTD ($8.0M), SAKAR HEALTHCARE LIMITED ($4.5M). Aurobindo Pharma Ltd processed 192 shipments to 6 destination countries.
What Cefixime Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CEFIXIME TABLETS 200MG(Cefixime Tablets | $372.0K | 8 |
| CEFIXIME TABLETS 200MG (Cefixime Viatris | $350.0K | 7 |
| CEFIXIME TABLETS 200MG (CEFIXIME VIATRIS200 MG) | $349.2K | 14 |
| CEFIXIME FOR ORAL SUSPENSION USP 200MG/5 | $250.0K | 5 |
| CEFIXIME TABLETS 200MG (CEFIXIME ARROW LAB 200 MG, COMPRIMA PELLICULA) | $243.1K | 9 |
| CEFIXIME FOR ORAL SUSPENSION 100 MG/5 ML | $182.6K | 6 |
| CEFIXIME TABLETS 400MG(AURO-CEFIXIME 400 | $150.0K | 3 |
| CEFIXIME TABLETS 200MG(CEFIXIME VIATRIS | $150.0K | 3 |
| CEFIXIME TABLETS 400MG (AURO-CEFIXIME 400) (23780 PACK) | $149.1K | 3 |
| CEFIXIME TABLETS 400MG (AURO-CEFIXIME 400) | $148.2K | 3 |
Aurobindo Pharma Ltd exports 146 distinct Cefixime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CEFIXIME TABLETS 200MG(Cefixime Tablets with 8 shipments worth $372.0K.
Regulatory Requirements: Exporting Cefixime to Key Markets
What Aurobindo Pharma Ltd must comply with to export Cefixime to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Cefixime Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MICRO LABS LIMITED | $19.1M | 697 | 25 | $27.4K |
| 3 | AUROBINDO PHARMA LTD ★ | $8.0M | 192 | 6 | $41.6K |
| 5 | SAKAR HEALTHCARE LIMITED | $4.5M | 91 | 11 | $50.0K |
| 8 | NECTAR LIFE SCIENCES LIMITED | $4.4M | 184 | 19 | $23.7K |
Aurobindo Pharma Ltd ranks #3 among 668 Indian Cefixime exporters. Average shipment value of $41.6K compared to the market average of $92.6K. The closest competitors by value are MICRO LABS LIMITED and SAKAR HEALTHCARE LIMITED.
Which Indian Ports Ship Cefixime Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 924 | 11.0% |
| JNPT | 498 | 5.9% |
| JNPT/ NHAVA SHEVA SEA | 480 | 5.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 449 | 5.3% |
| SAHAR AIR | 412 | 4.9% |
| DELHI AIR CARGO ACC (INDEL4) | 399 | 4.8% |
| DELHI AIR | 366 | 4.4% |
| AHEMDABAD ICD | 226 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefixime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefixime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 268 individual customs records matching Aurobindo Pharma Ltd exporting Cefixime, covering 146 formulations to 6 countries via 33 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 1,805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefixime Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Cefixime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Cefixime Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefixime. For current shipment-level data, contact TransData Nexus.